Metabolic Syndrome and Obesity – How Do They Affect Your Breast Cancer Risk?

Why Does This Study Matter?

Metabolic syndrome and obesity have important effects on breast cancer development and its course in postmenopausal women. New data provide important findings on how these conditions affect breast cancer risk and breast cancer-related mortality.

Study Details

Metabolic syndrome and obesity are associated with dysregulated cellular metabolism, but their relative contributions to breast cancer outcomes have not been fully defined. This new analysis included 63 thousand postmenopausal women with no previous breast cancer and normal mammograms.

Metabolic syndrome scores of 0, 1-2, or 3-4 were assigned based on high waist circumference, high blood pressure, high cholesterol, and a history of diabetes.

Researchers assessed outcomes such as breast cancer incidence and breast cancer-related deaths over more than 20 years of follow-up.

Findings: Differences Between Metabolic Syndrome and Obesity

Higher Metabolic Syndrome Scores and Poor-Prognosis Breast Cancer

After adjustment for body mass index (BMI), a high metabolic syndrome score (3-4) was strongly associated with breast cancers having a poorer prognosis. In particular, high scores were more common in estrogen receptor (ER)-positive and progesterone receptor (PR)-negative cancers, with a 1.47-fold increase in risk.

However, a high metabolic syndrome score was not associated with a marked increase in overall breast cancer incidence. This suggests that, although high scores increase the occurrence of poor-prognosis cancer subtypes, they do not increase the overall risk of developing breast cancer.

Metabolic Syndrome and Breast Cancer Mortality Risk

A higher metabolic syndrome score (3-4) was associated with a 44% increase in the risk of death from breast cancer (HR, 1.44) and a 53% increase in the risk of death after breast cancer (HR, 1.53). This indicates that women with high scores were more likely to die both from breast cancer and after cancer treatment.

Obesity: Higher Incidence, More Favorable Prognosis

The Effect of Obesity on Breast Cancer Incidence

After adjustment for metabolic syndrome score, obesity was significantly associated with higher overall breast cancer incidence. The association became more pronounced as body mass index (BMI) increased. These obesity-related cancers generally had a more favorable prognosis, particularly ER-positive and PR-positive types. Obesity was not significantly associated with poorer-prognosis cancers.

The Relationship Between Obesity and Breast Cancer Mortality

The risk of death from breast cancer was significantly higher only among women with severe obesity (BMI ≥ 35). However, obesity was also associated with deaths after breast cancer treatment.

Practical Application: Targeting Metabolic Syndrome and Obesity

The researchers summarize their study as follows: "Metabolic syndrome and obesity represent separate targets for breast cancer prediction and prevention strategies. Reducing obesity will have a greater impact on deaths from breast cancer than on breast cancer incidence. Lowering metabolic syndrome scores will have a greater impact on breast cancer mortality by identifying women at risk of poor-prognosis ER-positive, PR-negative breast cancer."

Conclusion

Metabolic syndrome and obesity are important factors affecting breast cancer risk and its course. These findings provide important data to consider when developing breast cancer prevention and treatment strategies. Approaches targeting both metabolic syndrome and obesity may therefore produce more effective outcomes in the fight against breast cancer.